Biotech News
Aveanna Healthcare Holdings Announces Fourth Quarter and Full Year 2025 Financial Results
Fourth Quarter Revenue was $662.5 million, a 27.4% increase over the prior year period Fourth Quarter Net income was $178.8 million compared to $29.2 million for the prior year period Adjusted EBITDA for Q4 2025 was $85.0 million, a 54.0% increase over the prior year period Maintained Full Year
